The Readout Loud

A podcast by STAT - Thursdays

Thursdays

Categories:

336 Episodes

  1. Episode 55: The fate of Bristol-Myers-Celgene, the tragedy of SIDS, and health tech's challenges

    Published: 3/28/2019
  2. Episode 54: Another big Alzheimer’s failure, postpartum progress, and Long Island shores

    Published: 3/21/2019
  3. Episode 53: How startups stop, the new FDA boss, and Theranos on the big screen

    Published: 3/14/2019
  4. Episode 52: Every conceivable angle of Scott Gottlieb's FDA resignation

    Published: 3/7/2019
  5. Episode 51: CEOs at the Senate, merger mania, and sleuthing startups

    Published: 2/28/2019
  6. Episode 50: A big scoop on opioid marketing

    Published: 2/22/2019
  7. Episode 49: Painkiller racketeering, the limits of genetic tests, and pharma's day on the Hill

    Published: 2/21/2019
  8. Episode 48: The AI hype machine, ketamine's future, and the rocky path ahead for NASH

    Published: 2/14/2019
  9. Episode 47: A bad day for bold biotech, campaign 2020, and where do drugs come from?

    Published: 2/7/2019
  10. Episode 46: Another Alzheimer's setback, crypto for biotech, and a blessing of unicorns

    Published: 1/31/2019
  11. Episode 45: CRISPR upheaval, Celgene's chutzpah, and canine genomics

    Published: 1/24/2019
  12. Episode 44: FDA furloughs, '80s pop radio, and video game therapeutics

    Published: 1/17/2019
  13. Episode 43: A people's history of J.P. Morgan

    Published: 1/10/2019
  14. Episode 42: Parsing Bristol-Myers-Celgene, grousing about JPM, and how to not be boring

    Published: 1/3/2019
  15. Episode 41: Watson's latest stumble, a glimpse into the crystal ball, and revisiting Sarepta

    Published: 12/20/2018
  16. Episode 40: Gilead’s new boss, the year that was, and the thing about DNA tests

    Published: 12/13/2018
  17. Episode 39: Using the word 'cure,' an FDA loophole, & making biotech history

    Published: 12/6/2018
  18. Episode 38: Your guide to the #CRISPRbabies controversy

    Published: 11/29/2018
  19. Episode 37: The biggest-ever IPO, drug prices rising in tandem, and burner Twitter accounts

    Published: 11/15/2018
  20. Episode 36: What the midterms mean, a golden age on hold, and the $4 million drug

    Published: 11/8/2018

15 / 17

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.